Anti-fibrotic agent
Phase 1
Therapeutic Area: Cardio-renal-metabolic Diseases
This compound is under investigation, further information will be available soon.
Phase 1
Therapeutic Area: Cardio-renal-metabolic Diseases
This compound is under investigation, further information will be available soon.